Ma J - Search Results

1

APOBEC mutational signature predicts prognosis and immunotherapy response in nonsmoking patients with lung adenocarcinoma.

Ma J, Yang X, Zhang J, Antonoff MB, Wu Q, Ji H. Ma J, et al. Transl Lung Cancer Res. 2023 Mar 31;12(3):580-593. doi: 10.21037/tlcr-23-150. Transl Lung Cancer Res. 2023. PMID: 37057114 Free PMC article.

2

Prognostic value of PD-L1 expression in resected lung adenocarcinoma and potential molecular mechanisms.

Ma J, Chi D, Wang Y, Yan Y, Zhao S, Liu H, Jing J, Pu H, Zhang M. Ma J, et al. J Cancer. 2018 Sep 8;9(19):3489-3499. doi: 10.7150/jca.26155. eCollection 2018. J Cancer. 2018. PMID: 30310505 Free PMC article.

3

Sodium/glucose cotransporter 1-dependent metabolic alterations induce tamoxifen resistance in breast cancer by promoting macrophage M2 polarization.

Niu X, Ma J, Li J, Gu Y, Yin L, Wang Y, Zhou X, Wang J, Ji H, Zhang Q. Niu X, et al. Among authors: ma j. Cell Death Dis. 2021 May 18;12(6):509. doi: 10.1038/s41419-021-03781-x. Cell Death Dis. 2021. PMID: 34006822 Free PMC article.

4

CD8⁺ T Cell-Associated Gene Signature Correlates With Prognosis Risk and Immunotherapy Response in Patients With Lung Adenocarcinoma.

Zhang M, Ma J, Guo Q, Ding S, Wang Y, Pu H. Zhang M, et al. Among authors: ma j. Front Immunol. 2022 Feb 22;13:806877. doi: 10.3389/fimmu.2022.806877. eCollection 2022. Front Immunol. 2022. PMID: 35273597 Free PMC article.

5

Glucocorticoid receptor regulates the epithelial-mesenchymal transition process through GR/ZEB1/E-cad and is involved in breast cancer endocrine drug resistance-a bioinformatics analysis.

Tang Y, Ma J, Zhang H, Ma W, Ma W, O'Keefe TJ, Pratap A, Yamada A, Wang L, Gao Y, Zhang Q, Zhao W. Tang Y, et al. Among authors: ma w, ma j. Transl Cancer Res. 2023 Nov 30;12(11):3129-3146. doi: 10.21037/tcr-23-1628. Epub 2023 Nov 24. Transl Cancer Res. 2023. PMID: 38130302 Free PMC article.

6

αPD-1 immunotherapy promotes IL-17A production and promotes the formation of acute radiation-induced lung injury.

Liu S, Liu L, Ma J, Li J, Wang L, Xu J, Hu S. Liu S, et al. Among authors: ma j. Am J Cancer Res. 2024 Jun 15;14(6):2881-2893. doi: 10.62347/WDOC4830. eCollection 2024. Am J Cancer Res. 2024. PMID: 39005666 Free PMC article.

7

Apatinib-induced NF-κB inactivation sensitizes triple-negative breast cancer cells to doxorubicin.

Tang D, Ma J, Chu Z, Wang X, Zhao W, Zhang Q. Tang D, et al. Among authors: ma j. Am J Transl Res. 2020 Jul 15;12(7):3741-3753. eCollection 2020. Am J Transl Res. 2020. PMID: 32774731 Free PMC article.

8

Identification and Validation of Immune-Related Long Non-Coding RNA Signature for Predicting Immunotherapeutic Response and Prognosis in NSCLC Patients Treated With Immunotherapy.

Ma J, Zhang M, Yu J. Ma J, et al. Front Oncol. 2022 Jul 4;12:899925. doi: 10.3389/fonc.2022.899925. eCollection 2022. Front Oncol. 2022. PMID: 35860577 Free PMC article.

9

Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer.

Liu J, Ma J, Zhang Q. Liu J, et al. Among authors: ma j. Front Genet. 2022 Aug 25;13:929870. doi: 10.3389/fgene.2022.929870. eCollection 2022. Front Genet. 2022. PMID: 36092879 Free PMC article.

10

Expression of glucose transporter-1 in follicular lymphoma affected tumor-infiltrating immunocytes and was related to progression of disease within 24 months.

Deng Y, Ma J, Zhao S, Yang M, Sun Y, Zhang Q. Deng Y, et al. Among authors: ma j. Transl Oncol. 2023 Feb;28:101614. doi: 10.1016/j.tranon.2022.101614. Epub 2022 Dec 29. Transl Oncol. 2023. PMID: 36584488 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38,591 results

Search Page

Filters